Who are ▶︎ STRM.BIO's investors?

▶︎ STRM.BIO's investors include Ascension Ventures, Breakout Labs, Breakout Ventures, Delos Capital, NYBC Ventures, KdT Ventures.

▶︎ STRM.BIO

Founded 2019 · 18 employees on LinkedIn · 6 known investors

STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients. The company operates in the biotech sector, focused on advancing gene therapy for patients worldwide.

Biotech Deep Tech Healthtech Longevity Medical Devices

Founders & leadership

Michael LutherinCEO

Investors · 6

Ascension VenturesSaint Louis · $10M – $20M

Breakout Labs

Breakout VenturesSan Francisco · $500K – $6M

Delos CapitalCambridge

NYBC VenturesNew York

KdT VenturesreportedAustin · $500K – $3M

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2022	$2.1M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does ▶︎ STRM.BIO do?: STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients. The company operates in the biotech sector, focused on advancing gene therapy for patients worldwide.
Who are ▶︎ STRM.BIO's investors?: ▶︎ STRM.BIO's investors include Ascension Ventures, Breakout Labs, Breakout Ventures, Delos Capital, NYBC Ventures, KdT Ventures.